Mangalam Drugs & Organics Ltd
Company Profile
Business description
Mangalam Drugs & Organics Ltd commenced its manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. The company is engaged in the manufacture and sale of APIs for various therapeutic segments, including anti-malaria, anti-retroviral, and anti-hypertensive. It is approved by the Bill Clinton Foundation. The company is actively producing Pyronaridine Tetraphosphate, a new API used in antimalarial treatments. The company has received prequalification from the World Health Organization (WHO) for both micronized and non-micronized forms of Pyronaridine Phosphate.
Contact
P. D'Mello Road
Rupam Building, 3rd Floor, No. 239
Near General Post Office
MumbaiMH400001
INDT: +91 2222616200
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
480
Stocks News & Analysis
stocks
Are small caps finally back?
stocks
Chart of the Week: Modest earnings growth at odds with overvalued bank shares
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,329.10 | 50.90 | 0.55% |
CAC 40 | 8,256.35 | 49.48 | 0.60% |
DAX 40 | 24,139.84 | 11.29 | -0.05% |
Dow JONES (US) | 46,589.73 | 0.68 | -0.00% |
FTSE 100 | 9,591.42 | 76.42 | 0.80% |
HKSE | 25,967.98 | 186.21 | 0.72% |
NASDAQ | 22,735.70 | 4.69 | -0.02% |
Nikkei 225 | 48,641.61 | 666.18 | -1.35% |
NZX 50 Index | 13,377.10 | 70.66 | 0.53% |
S&P 500 | 6,704.41 | 5.01 | 0.07% |
S&P/ASX 200 | 9,032.80 | 46.60 | 0.52% |
SSE Composite Index | 3,922.41 | 8.65 | 0.22% |